Last reviewed · How we verify
sufentanil-ropivacaine combination
sufentanil-ropivacaine combination is a Small molecule drug developed by Peking University First Hospital. It is currently FDA-approved. Also known as: epidural analgesia using the sufentanil-ropivacaine combination.
Sufentanil-ropivacaine combination is a small molecule modality used in epidural labor analgesia, as studied in clinical trials such as NCT05698407. This combination is being investigated for its effects on neonatal outcomes, among other conditions, including pregnancy-related and postpartum depression.
At a glance
| Generic name | sufentanil-ropivacaine combination |
|---|---|
| Also known as | epidural analgesia using the sufentanil-ropivacaine combination |
| Sponsor | Peking University First Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Anesthetic Techniques for Early Recovery After Ankle Arthroscopy (NA)
- Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection (NA)
- Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy (NA)
- Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia (PHASE4)
- Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery (PHASE4)
- Sacral Canal Block for Hip Replacement the Efficacy and Safety of Controlled Intraoperative Hypotension (NA)
- Effects of Ropivacaine Concentrations on Prolonged Labor Analgesia (NA)
- Peripheral Nerve Blocks vs Selective Spinal Anesthesia in Patients With Femur Fracture (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- sufentanil-ropivacaine combination CI brief — competitive landscape report
- sufentanil-ropivacaine combination updates RSS · CI watch RSS
- Peking University First Hospital portfolio CI
Frequently asked questions about sufentanil-ropivacaine combination
What is sufentanil-ropivacaine combination?
Who makes sufentanil-ropivacaine combination?
Is sufentanil-ropivacaine combination also known as anything else?
What development phase is sufentanil-ropivacaine combination in?
Related
- Manufacturer: Peking University First Hospital — full pipeline
- Also known as: epidural analgesia using the sufentanil-ropivacaine combination
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing